Plus Therapeutics (PSTV) announced it reported stockholders’ equity of $3M and therefore satisfied Nasdaq Listing Rule 5550(b)(1), as of June 30, 2025. The Equity Rule requires listed companies to maintain a minimum of $2.5 million in stockholders’ equity.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PSTV:
- Buy Rating for Plus Therapeutics: Strategic Market Launch and Promising Financial Outlook
- Plus Therapeutics Reports Strong Q2 2025 Results
- Plus Therapeutics Awaits Nasdaq Compliance Confirmation
- Plus Therapeutics presents data from analysis of CNSide CSF Assay
- Plus Therapeutics Granted Continued Nasdaq Listing